BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38025403)

  • 21. Identification of serological biomarker profiles associated with total joint replacement in osteoarthritis patients.
    Arends RHGP; Karsdal MA; Verburg KM; West CR; Bay-Jensen AC; Keller DS
    Osteoarthritis Cartilage; 2017 Jun; 25(6):866-877. PubMed ID: 28115232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostics for pain in osteoarthritis: Do clinical measures predict pain after total joint replacement?
    Barroso J; Wakaizumi K; Reckziegel D; Pinto-Ramos J; Schnitzer T; Galhardo V; Apkarian AV
    PLoS One; 2020; 15(1):e0222370. PubMed ID: 31914126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Associated With Opioid Use in Presurgical Knee, Hip, and Spine Osteoarthritis Patients.
    Power JD; Perruccio AV; Gandhi R; Veillette C; Davey JR; Lewis SJ; Syed K; Mahomed NN; Rampersaud YR
    Arthritis Care Res (Hoboken); 2019 Sep; 71(9):1178-1185. PubMed ID: 30629338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
    Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
    Osteoarthritis Cartilage; 2008 Feb; 16(2):137-62. PubMed ID: 18279766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.
    Hochberg MC; Altman RD; April KT; Benkhalti M; Guyatt G; McGowan J; Towheed T; Welch V; Wells G; Tugwell P;
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):465-74. PubMed ID: 22563589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between pre-surgical daily opioid use and short-term outcomes following knee or hip arthroplasty: a prospective, exploratory cohort study.
    Naylor JM; Pavlovic N; Farrugia M; Ogul S; Hackett D; Wan A; Adie S; Brady B; Gray L; Wright R; Nazar M; Xuan W
    BMC Musculoskelet Disord; 2020 Jun; 21(1):398. PubMed ID: 32571280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate opioid dispensing in patients with knee and hip osteoarthritis: a population-based cohort study.
    Thorlund JB; Turkiewicz A; Prieto-Alhambra D; Englund M
    Osteoarthritis Cartilage; 2020 Feb; 28(2):146-153. PubMed ID: 31669311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of neuromuscular training (NEMEX-TJR) on patient-reported outcomes and physical function in severe primary hip or knee osteoarthritis: a controlled before-and-after study.
    Ageberg E; Nilsdotter A; Kosek E; Roos EM
    BMC Musculoskelet Disord; 2013 Aug; 14():232. PubMed ID: 23924144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial.
    Ishijima M; Nakamura T; Shimizu K; Hayashi K; Kikuchi H; Soen S; Omori G; Yamashita T; Uchio Y; Chiba J; Ideno Y; Kubota M; Kurosawa H; Kaneko K;
    Arthritis Res Ther; 2014 Jan; 16(1):R18. PubMed ID: 24443804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonrandom evolution of end-stage osteoarthritis of the lower limbs.
    Shakoor N; Block JA; Shott S; Case JP
    Arthritis Rheum; 2002 Dec; 46(12):3185-9. PubMed ID: 12483722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic use for knee and hip osteoarthritis in community-dwelling elders.
    Marcum ZA; Perera S; Donohue JM; Boudreau RM; Newman AB; Ruby CM; Studenski SA; Kwoh CK; Simonsick EM; Bauer DC; Satterfield S; Hanlon JT;
    Pain Med; 2011 Nov; 12(11):1628-36. PubMed ID: 21992521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
    Emery P; Koncz T; Pan S; Lowry S
    Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are medical comorbidities contributing to the use of opioid analgesics in patients with knee osteoarthritis?
    King LK; Marshall DA; Jones CA; Woodhouse LJ; Ravi B; Faris PD; Hawker GA;
    Osteoarthritis Cartilage; 2020 Aug; 28(8):1030-1037. PubMed ID: 32387761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of peri-operative prescription of non-steroidal anti-inflammatory drugs with continued prescription of opioids after total knee arthroplasty: a retrospective claims-based cohort study.
    Hussain N; Brull R; Gilron I; Weaver TE; Shahzad H; D'Souza RS; Abdel-Rasoul M; Clarke H; McCartney CJL; Abdallah FW
    Anaesthesia; 2024 Jul; 79(7):725-734. PubMed ID: 38385772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How is postoperative pain after hip and knee replacement managed? An analysis of two large hospitals in Australia.
    Ferreira GE; Patanwala AE; Turton H; Langford AV; Harris IA; Maher CG; McLachlan AJ; Glare P; Lin CC
    Perioper Med (Lond); 2024 May; 13(1):49. PubMed ID: 38822448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cartilage degradation marker, urinary CTX-II, is associated with the risk of incident total joint replacement in postmenopausal women. A 18 year evaluation of the OFELY prospective cohort.
    Garnero P; Sornay-Rendu E; Chapurlat R
    Osteoarthritis Cartilage; 2020 Apr; 28(4):468-474. PubMed ID: 31982562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative.
    Kingsbury SR; Hensor EM; Walsh CA; Hochberg MC; Conaghan PG
    Arthritis Res Ther; 2013; 15(5):R106. PubMed ID: 24008023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis.
    Gore M; Sadosky A; Leslie D; Tai KS; Seleznick M
    Clin Ther; 2011 Dec; 33(12):1914-31. PubMed ID: 22088416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The burden of hip and knee osteoarthritis in Finnish occupational healthcare.
    Summanen M; Ukkola-Vuoti L; Kurki S; Tuominen S; Madanat R
    BMC Musculoskelet Disord; 2021 May; 22(1):501. PubMed ID: 34051771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analgesic use and risk of recurrent falls in participants with or at risk of knee osteoarthritis: data from the Osteoarthritis Initiative.
    Lo-Ciganic WH; Floden L; Lee JK; Ashbeck EL; Zhou L; Chinthammit C; Purdy AW; Kwoh CK
    Osteoarthritis Cartilage; 2017 Sep; 25(9):1390-1398. PubMed ID: 28385483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.